[Federal Register Volume 67, Number 48 (Tuesday, March 12, 2002)]
[Notices]
[Page 11107]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-5900]


-----------------------------------------------------------------------

DEPARTMENT OF DEFENSE

Department of the Army


Availability for Non-Exclusive, Exclusive, or Partially Exclusive 
Licensing of U.S. Patent Application Concerning Diagnosis of Exposure 
to Toxic Agents by Measuring Distinct Patterns in the Levels of 
Specific Genes

AGENCY: Department of the Army, DoD.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: In accordance with 37 CFR 404.6, announcement is made of the 
availability for licensing of U.S. Patent Application No. 09/876,249 
entitled ``Diagnosis of Exposure to Toxic Agents by Measuring Distinct 
Patterns in the Levels of Specific Genes'' filed June 7, 2001. Foreign 
rights are also available (PCT/US00/02756). The United States 
Government as represented by the Secretary of the Army has rights in 
this invention.

ADDRESSES: Commander, U.S. Army Medical Research and Materiel Command, 
ATTN: Command Judge Advocate, MCMR-JA, 504 Scott Street, Fort Detrick, 
Frederick, Maryland 21702-5012.

FOR FURTHER INFORMATION CONTACT: For patent issues, Ms. Elizabeth 
Arwine, Patent Attorney, (301) 619-7808. For licensing issues, Dr. Paul 
Mele, Office of Research & Technology Assessment, (301) 619-6664, both 
at telefax (301) 619-5034.

SUPPLEMENTARY INFORMATION: The present invention relates to a novel 
method of diagnosing the exposure to toxic agents based on relative 
ratios or changes in levels of the genes/proteins in mammalian tissue 
or body fluids from normal levels. The present invention further 
relates to compositions and uses thereof for treating lethal shock 
induced by toxic agents.

Luz D. Ortiz,
Army Federal Register Liaison Officer.
[FR Doc. 02-5900 Filed 3-11-02; 8:45 am]
BILLING CODE 3710-08-M